ArticleJournal of family medicine and primary care2026
Knowledge and attitude toward Pap smear, human papilloma virus, and human papilloma virus vaccine among Saudi women.
Article in Journal of family medicine and primary care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: A Pap smear is a screening tool for human papillomavirus (HPV) and cervical tissue changes. HPV vaccines protect against HPV-related cancers, including cervical cancer. This study aimed to assess the awareness levels and attitudes regarding Pap smear, HPV, and HPV vaccine among Saudi women. Methods: A descriptive study was conducted among 413 Saudi women aged ≥ 18 years living in Riyadh, using an online self-administered questionnaire that was collected between the period from August 2024 to February 2025. The survey collected sociodemographic data and assessed knowledge and attitudes toward cervical cancer, Pap smears, HPV, and the HPV vaccine. Results: Among the 413 respondents, 72.9% had heard of the Pap smear, but only 36.6% had undergone the test. About 48.2% were aware of the HPV vaccine, yet only 2.9% had received it. Most participants demonstrated excellent knowledge about Pap smears, HPV, and the HPV vaccine. Awareness of the Pap smear and HPV vaccine was associated with significantly lower odds of poor knowledge. A majority expressed positive attitudes, indicating willingness to undergo a Pap smear if recommended by their doctor and affirming that the test is necessary for all women. A statistically significant positive correlation was found between knowledge and attitude scores. Conclusion: Although most participants recognized the importance of the HPV vaccine and Pap smear screening, vaccine uptake remained alarmingly low, reflecting a gap between awareness and action.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.